CAS No. |
103429-32-9 |
|---|---|
英文名称 |
(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((R)-2-amino-3-phenylpropanamido)-10-(3-guanidinopropyl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide |
别名 |
H-D-PHE-CYS-TYR-D-TRP-ARG-THR-PEN-THR-NH2;D-PHE-CYS-TYR-D-TRP-ARG-THR-PEN-THR-NH2;CTAP;CYS2, TYR3, ARG5, PEN7-AMIDE;H-D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(Cys2-Pen7);CTAP, ≥95%;7)-disulfide;M.W. 1104.30 C51H69N13O11S2 |
标准英文名 |
(4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((R)-2-amino-3-phenylpropanamido)-10-(3-guanidinopropyl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-3,3-dimethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide |
分子式 |
C51H69N13O11S2 |
分子量 |
1104.33 |
精确分子量 |
1103.47 |
SMILES |
C[C@@H](O)[C@H](NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C23)NC(=O)[C@H](CC2=CC=C(O)C=C2)NC(=O)[C@@H](NC(=O)[C@H](N)CC2=CC=CC=C2)CSSC1(C)C)C(N)=O |
标准SMILES |
CC1(C)SSC[C@H](NC(=O)[C@H](N)CC2C=CC=CC=2)C(=O)N[C@@H](CC2=CC=C(O)C=C2)C(=O)N[C@H](CC2=CNC3=CC=CC=C23)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]1C(=O)N[C@@H]([C@@H](C)O)C(N)=O |
用途 |
CTAP is a potent and highly selective brain-penetrant μ-opioid receptor antagonist (IC50 = 3.5 nM) with over 1200-fold selectivity over δ-opioid receptors (IC50 = 4500 nM) and somatostatin receptors; it is used in the study of L-DOPA (HY-N0304)-induced dyskinesia (LID). |
InChIKey |
OFMQLVRLOGHAJI-FGHAYEPSSA-N |
|
|
评论 |
|---|